Condition: Type 1 Diabetes Mellitus · Type 2 Diabetes Mellitus · Sponsor: Hoffmann-La Roche
This is an open label, two-arm, randomized multi-center clinical device study in adult subjects with Type 1 diabetes (T1D) or insulin-dependent Type 2 diabetes (T2D) on a multiple daily injection (MDI) regime. The goal of the study is to investigate the impact of the Accu-Chek SmartGuide CGM solution on the change in overall time in range (TIR) of blood glucose concentrations of 70-180 mg/dl compared with that using self-monitoring of blood glucose (SMBG).
This description comes directly from the study's public registry record.
Study ID Reference: DC000129 Roche Diabetes Care Poland and Turkey · +48 22 481 55 00; 08002113636 · polska.diabetologia@roche.com; diyabetevi.turkey@roche.com
Always discuss trial participation with your own doctor first.
| Centrum Badań Klinicznych PI-House sp. z o.o. | Gdansk, Poland | Recruiting |
| Diabetes Technology Center, Jagiellonian University Medical College | Krakow, Poland | Recruiting |
| NZOZ Neuromed | Kraśnik, Poland | Recruiting |
| NZOZ Neuromed | Lublin, Poland | Recruiting |
| Institute of Rural Health | Lublin, Poland | Recruiting |
| KO-MED Centra Kliniczne Lublin II | Lublin, Poland | Recruiting |
| BioResearch Group Sp. z o. o. | Nadarzyn, Poland | Recruiting |
| Nbr Polska | Warsaw, Poland | Recruiting |
| Clinic of Internal Diseases, Endocrinology and Diabetology State Medical Institute MSWiA | Warsaw, Poland | Recruiting |
| ETG Warszawa | Warsaw, Poland | Recruiting |
| Baskent University Department of Endocrinology and Metabolism | Adana, Turkey (Türkiye) | Recruiting |
| Bakırköy Sadi Konuk Training and Research Hospital | Bakirkoy Istanbul, Turkey (Türkiye) | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06704672